AngioTx was founded in 2015 to provide safe and effective ways to regenerate blood vessels. The company’s core technology, V-10, originated from interdisciplinary research conducted at Rice University and the Texas Heart Institute. V-10 is a unique injectable drug that creates a scaffold in the muscle. This scaffolding provides i) support and ii) biochemical signals to instruct the body to create mature blood vessels. V-10 is a platform technology that helps build highways for life. It has received national acclaim in the scientific media, has been featured in numerous peer reviewed publications and has received numerous grants from both federal and private funding agencies.
Location: United States, New Jersey, Newark
Phone: +1 678-613-1386
Founded date: 2015